I dont understand why there aren't more generic competitors. If 20 years ago companies were profitable selling at a much lower price, surely a new biotech compa

I dont understand why there aren't more generic competitors. If 20 years ago companies were profitable selling at a much lower price, surely a new biotech company could do the same now? We're all looking for startup ideas with subscription models, this looks obvious.